An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim Versus Chloroquine and Nonrelapse Therapy With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria

Trial Profile

An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim Versus Chloroquine and Nonrelapse Therapy With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 03 May 2018

At a glance

  • Drugs Dihydroartemisinin/piperaquine (Primary) ; Chloroquine; Primaquine
  • Indications Vivax malaria
  • Focus Therapeutic Use
  • Acronyms CuraVivax
  • Most Recent Events

    • 26 Apr 2018 Planned initiation date changed from 1 Jan 2018 to 1 May 2018.
    • 10 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top